127 related articles for article (PubMed ID: 15618754)
1. CYP2D in the brain.
Funae Y; Kishimoto W; Cho T; Niwa T; Hiroi T
Drug Metab Pharmacokinet; 2003; 18(6):337-49. PubMed ID: 15618754
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain.
Kishimoto W; Hiroi T; Shiraishi M; Osada M; Imaoka S; Kominami S; Igarashi T; Funae Y
Endocrinology; 2004 Feb; 145(2):699-705. PubMed ID: 14563706
[TBL] [Abstract][Full Text] [Related]
3. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.
Bromek E; Haduch A; Daniel WA
Eur J Pharmacol; 2010 Jan; 626(2-3):171-8. PubMed ID: 19818757
[TBL] [Abstract][Full Text] [Related]
4. Effect of psychotropic drugs on the 21-hydroxylation of neurosteroids, progesterone and allopregnanolone, catalyzed by rat CYP2D4 and human CYP2D6 in the brain.
Niwa T; Okada K; Hiroi T; Imaoka S; Narimatsu S; Funae Y
Biol Pharm Bull; 2008 Mar; 31(3):348-51. PubMed ID: 18310890
[TBL] [Abstract][Full Text] [Related]
5. Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR.
Hiroi T; Imaoka S; Chow T; Funae Y
Biochim Biophys Acta; 1998 May; 1380(3):305-12. PubMed ID: 9555068
[TBL] [Abstract][Full Text] [Related]
6. Dopamine formation from tyramine by CYP2D6.
Hiroi T; Imaoka S; Funae Y
Biochem Biophys Res Commun; 1998 Aug; 249(3):838-43. PubMed ID: 9731223
[TBL] [Abstract][Full Text] [Related]
7. Isoform-selective metabolism of mianserin by cytochrome P-450 2D.
Chow T; Hiroi T; Imaoka S; Chiba K; Funae Y
Drug Metab Dispos; 1999 Oct; 27(10):1200-4. PubMed ID: 10497148
[TBL] [Abstract][Full Text] [Related]
8. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.
Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y
Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752
[TBL] [Abstract][Full Text] [Related]
9. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.
Chow T; Imaoka S; Hiroi T; Funae Y
Drug Metab Dispos; 1999 Feb; 27(2):188-92. PubMed ID: 9929501
[TBL] [Abstract][Full Text] [Related]
10. The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol.
Narimatsu S; Kazamori D; Masuda K; Katsu T; Funae Y; Naito S; Nakura H; Yamano S; Hanioka N
Biochem Pharmacol; 2009 Mar; 77(5):920-31. PubMed ID: 19059219
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms.
Danek PJ; Daniel WA
Cells; 2021 Dec; 10(12):. PubMed ID: 34943983
[No Abstract] [Full Text] [Related]
12. The endogenous substrates of brain CYP2D.
Wang X; Li J; Dong G; Yue J
Eur J Pharmacol; 2014 Feb; 724():211-8. PubMed ID: 24374199
[TBL] [Abstract][Full Text] [Related]
13. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.
Danek PJ; Daniel WA
Cells; 2022 Nov; 11(21):. PubMed ID: 36359909
[TBL] [Abstract][Full Text] [Related]
14. Regional distribution of cytochrome P450 2D1 in the rat central nervous system.
Norris PJ; Hardwick JP; Emson PC
J Comp Neurol; 1996 Mar; 366(2):244-58. PubMed ID: 8698885
[TBL] [Abstract][Full Text] [Related]
15. Regional and cellular distribution of CYP2D subfamily members in rat brain.
Miksys S; Rao Y; Sellers EM; Kwan M; Mendis D; Tyndale RF
Xenobiotica; 2000 Jun; 30(6):547-64. PubMed ID: 10923858
[TBL] [Abstract][Full Text] [Related]
16. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.
Haduch A; Bromek E; Daniel WA
Eur J Pharmacol; 2011 Jan; 651(1-3):51-8. PubMed ID: 21115002
[TBL] [Abstract][Full Text] [Related]
17. Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6.
Niwa T; Hiroi T; Tsuzuki D; Yamamoto S; Narimatsu S; Fukuda T; Azuma J; Funae Y
Brain Res Mol Brain Res; 2004 Oct; 129(1-2):117-23. PubMed ID: 15469888
[TBL] [Abstract][Full Text] [Related]
18. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.
Yue J; Miksys S; Hoffmann E; Tyndale RF
J Psychiatry Neurosci; 2008 Jan; 33(1):54-63. PubMed ID: 18197273
[TBL] [Abstract][Full Text] [Related]
19. Expression and localisation of CYP2D enzymes in rat basal ganglia.
Riedl AG; Watts PM; Edwards RJ; Schulz-Utermoehl T; Boobis AR; Jenner P; Marsden CD
Brain Res; 1999 Mar; 822(1-2):175-91. PubMed ID: 10082895
[TBL] [Abstract][Full Text] [Related]
20. Effect of genetic polymorphism on the inhibition of dopamine formation from p-tyramine catalyzed by brain cytochrome P450 2D6.
Niwa T; Shizuku M; Yamano K
Arch Biochem Biophys; 2017 Apr; 620():23-27. PubMed ID: 28347660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]